
Bioorganic and Medicinal Chemistry Letters p. 1453 - 1458 (1999)
Update date:2022-08-04
Topics:
Duan, James J.-W
Chen, Lihua
Xue, Chu-Biao
Wasserman, Zelda R.
Hardman, Karl D.
Covington, Maryanne B.
Copeland, Robert R.
Arner, Elizabeth C.
Decicco, Carl P.
A novel series of 13- and 14-membered macrocyclic amines was developed by linking the P1 and P2' groups. The synthesis entails stereoselective Frater alkylation to install the anti-succinate configuration and macrocyclic amination via nucleophilic displacement. This strategy resulted in a new class of conformationally constrained inhibitors that are potent and selective for MMP-8 and 9 over MMP-1 and 3.
View MoreVanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Hubei Xiangxi Chemical Industry Co.,Ltd
Contact:+86-710-3454830
Address:No.7, Daqing East Road, Xiangfan City, Hubei Province, China
Jiangxi Hessence Chemicals Co., Ltd.
Contact:+86 796 3511924
Address:Chengxi Industrial Park, Jishui County, Jiangxi Province 331600 China.
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Doi:10.1039/a607200c
(1997)Doi:10.1021/ja01588a037
(1956)Doi:10.1021/om970211l
(1997)Doi:10.1246/cl.1994.1013
(1994)Doi:10.1021/jo500061w
(2014)Doi:10.1021/ja00097a026
(1994)